Targeting SLC1A5, SLC7A5, SLC38A1, and NUPR1, along with GLS inhibition, disrupts Gln metabolism, increases oxidative stress, and enhances radiosensitivity in PCa. This evidence concerns the gene SLC38A1 and posterior cortical atrophy.